Beam Therapeutics, Inc. (BEAM)
27.59
-0.29
(-1.04%)
USD |
NASDAQ |
Feb 20, 16:00
27.73
+0.14
(+0.51%)
After-Hours: 20:00
Beam Therapeutics SG&A Expense (Quarterly) : 26.74M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 30.51M |
| Twist Bioscience Corp. | 69.74M |
| Pacific Biosciences of California, Inc. | 34.05M |
| Stryker Corp. | 2.227B |
| Zimmer Biomet Holdings, Inc. | 872.30M |